Abstract:Fluorescence methods are important tools to identify RNA-binding small molecules and further employed to study RNA–protein interactions. Most reported fluorescence strategies are based on covalent labeling of ligand or RNA, which can impede the binding between them to some extent, or light-off fluorescent indicator displacement methods, which ask for particular indicators. Herein, a label-free fluorescence strategy based on the light-on aggregation-induced emission (AIE) feature of tetraphenylethene (TPE) derivative to screen RNA-binding small molecules is presented. As a result of electrostatic interaction, the selected peptides can induce self-assembly of the TPE derivative to produce strong fluorescent emission; when the peptides are bound to RNA molecules, the TPE derivative is in the deaggregated form and shows no or minimum fluorescence. Based on the phenomenon, a competitive displacement assay combined with the TPE reporter was employed to characterize selected small molecules for their binding abilities to HIV-I RNAs. This AIE feature enables the fluorescence-off state of the TPE derivative in the presence of RNA–peptide complex to be "lightened up" quickly as the RNA-binding molecule is introduced and the peptide is competitively released. This strategy was carried out to test several small molecule binders, and the results are consistent with previous reports. This report gives an inspiring example of AIE-based fluorescent assay for HIV-I RNA-binding molecule screening, which may further be explored to build a drug screening platform for RNA–protein interference.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c03010?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c03010</a>.Synthesis of the TPE derivative; data fitting; zeta potentials (Table S1); the fitting equation between the fraction of peptide bound and the ligand concentrations (Table S2); the thermodynamic parameters obtained from the ITC experiments (Table S3); <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra of the TPE derivative (Figure S1); the effects of several biomolecules on the fluorescence of the TPE derivative (Figure S2); the fluorescence of the TPE derivative in the systems of Rev peptide with different compounds (Figure S3); confocal laser scanning images (Figure S4); the structural formula of the 10 small molecules (Figure S5); the effect of small molecules on the TPE fluorescence (Figure S6); the fluorescence spectra of the TPE derivative in the displacement assays (Figure S7); ITC profiles for the titration of ligands to HIV-I RNAs (Figure S8); and the energy distribution diagram in the ITC process (Figure S9) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c03010/suppl_file/ac0c03010_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Study on the Interactions Between Anti-Hiv-1 Active Compounds with Trans-Activation Response RNA by Affinity Capillary Electrophoresis

Study On The Interaction Of Human Immunodeficiency Virus Inhibitor, Trans-Activitor Of Transcription Protein And Ribonucleic Acid System By Capillary Electrophoresis

Studies of binding constants and interaction of drugs to -activation response RNA by capillary electrophoresis

Capillary Zone Electrophoretic Separation of Four Novel Compounds Active Against Human Immunodeficiency Virus Type 1

Metal-Enhanced Aggregation-Induced Emission Strategy for the HIV-I RNA-Binding Ligand Assay

[Determination of the Binding Constants of Four Anti-Hiv-1 Active Compounds with Bovine Serum Albumin by Capillary Zone Electrophoresis].

TAR RNA selective targeting ruthenium(II) complexes as HIV-1 reverse transcriptase inhibitors: On exploring structure-activity relationships of multiple positions

A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor Ccr5 Heterodimer: Binding Affinity Versus Functional Activities

Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization.

Alpha,Alpha-Trehalose Derivatives Bearing Guanidino Groups As Inhibitors to Hiv-1 Tat-Tar Rna Interaction in Human Cells

Terpyridyl ruthenium complexes as visible spectral probe for poly(A) RNA and bifunctional TAR RNA binders and HIV-1 reverse transcriptase inhibitors

Study on the interaction between HIV reverse transcriptase and its non-nucleoside inhibitor nevirapine by capillary electrophoresis.

The Serum Levels and Roles of Regulated Upon Activation Normal T Cell Expressed and Secreted and Monocyte Chemoattractant Protein-1 in Human Immunodeficiency Virus-1 Infected Patients

A Light-Up Strategy with Aggregation-Induced Emission for Identification of HIV-I RNA-Binding Small Molecules

Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA

Interactive Study Between Two Types of 1-[2-(hydroxyethoxy)methyl]-6-naphthylmethylthymines and HIV-1 Reverse Transcriptase

Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors

Assessment of the susceptibility of mutant HIV-1 to antiviral agents.

Enzyme Hinders HIV-1 Tat Viral Transport and Real-Time Measured with Nanopores

Identifying the Molecular Mechanics and Binding Dynamics Characteristics of Potent Inhibitors to HIV‐1 Protease

The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis.